82 Chapter 5 References 1. Oronsky B, Reid T, Larson C, Knox SJ (2020) Locally advanced rectal cancer: The past, present, and future. Semin Oncol 47:85–92 2. Beets-Tan RGH, Lambregts DMJ, Maas M, et al (2018) Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 28:1465– 1475 3. Almeida RR, Souza D, Matalon SA, Hornick JL, Lee LK, Silverman SG (2021) Rectal MRI after neoadjuvant chemoradiation therapy: a pictorial guide to interpretation. Abdominal Radiology 46:3044–3057 4. Bates DDB, Shaish H, Gollub MJ, Harisinghani M, Lall C, Sheedy SP (2022) Multi-practice survey on MR imaging practice patterns in rectal cancer in the United States. Abdom Radiol (NY). 47(1):28-37. doi: 10.1007/s00261-021-03279-2 5. Gollub MJ, Arya S, Beets-Tan RG, et al (2018) Use of magnetic resonance imaging in rectal cancer patients: Society of Abdominal Radiology (SAR) rectal cancer disease-focused panel (DFP) recommendations 2017. Abdom Radiol (NY) 43:2893–2902 6. Seo N, Kim H, Cho MS, Lim JS (2019) Response Assessment with MRI after Chemoradiotherapy in Rectal Cancer: Current Evidences. Korean J Radiol 20:1003 7. Patel UB, Taylor F, Blomqvist L, et al (2011) Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol 29:3753–3760 8. Park JS, Park SY, Kim HJ, Cho SH, Kwak SG, Choi GS (2019) Long-Term oncologic outcomes after neoadjuvant chemoradiation followed by intersphincteric resection with coloanal anastomosis for locally advanced low rectal cancer. Dis Colon Rectum 62:408–416 9. Maas M, Lambregts DMJ, Nelemans PJ, et al (2015) Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment. Ann Surg Oncol 22:3873 10. van der Valk MJM, Hilling DE, Bastiaannet E, et al (2018) Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. The Lancet. 23;391(10139):25372545. doi: 10.1016/S0140-6736(18)31078-X 11. Rullier E, Vendrely V, Asselineau J, et al (2020) Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial. Lancet Gastroenterol Hepatol 5:465–474 12. van der Paardt MP, Zagers MB, Beets-Tan RGH, Stoker J, Bipat S (2013) Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. Radiology 269:101–112 13. Fernandes MC, Gollub MJ, Brown G (2022) The importance of MRI for rectal cancer evaluation. Surg Oncol 101739 14. Schurink NW, van Kranen SR, Roberti S, et al (2022) Sources of variation in multicenter rectal MRI data and their effect on radiomics feature reproducibility. Eur Radiol 32:1506–1516 15. Bogveradze N, el Khababi N, Schurink NW, et al (2022) Evolutions in rectal cancer MRI staging and risk stratification in The Netherlands. Abdom Radiol (NY) 47(1):38-47. doi: 10.1007/s00261021-03281-8 16. Siddiqui MRS, Gormly KL, Bhoday J, Balyansikova S, Battersby NJ, Chand M, Rao S, Tekkis P, Abulafi AM, Brown G (2016) Interobserver agreement of radiologists assessing the response of rectal cancers to preoperative chemoradiation using the MRI tumour regression grading (mrTRG). Clin Radiol 71:854–862
RkJQdWJsaXNoZXIy MjY0ODMw